Claire M. Davies

South Brisbane, QLD 4101, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer.

Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer.

Journal: Molecular pharmaceutics
Published: August 27, 2021

Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma.

Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma.

Journal: Cancers
Published: March 10, 2020

CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin.

CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin.

Journal: Oncogene
Published: June 23, 2018

Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases.

Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases.

Journal: American journal of cancer research
Published: October 05, 2017

L1 Retrotransposon Heterogeneity in Ovarian Tumor Cell Evolution.

L1 Retrotransposon Heterogeneity in Ovarian Tumor Cell Evolution.

Journal: Cell reports
Published: June 04, 2017

Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.

Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.

Journal: British journal of cancer
Published: November 10, 2015

Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.

Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.

Journal: Oncogene
Published: September 22, 2014

EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surface.

EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surface.

Journal: Oncogene
Published: November 24, 2013

AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation.

AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation.

Journal: Pathology
Published: December 11, 2012
Showing 1-9 of 9

Last Updated: 09/26/2026